FI893587A - Förfarande för framställning av icke-glykosylerad rekombinant-human-IL2 i dess reducerade form - Google Patents

Förfarande för framställning av icke-glykosylerad rekombinant-human-IL2 i dess reducerade form Download PDF

Info

Publication number
FI893587A
FI893587A FI893587A FI893587A FI893587A FI 893587 A FI893587 A FI 893587A FI 893587 A FI893587 A FI 893587A FI 893587 A FI893587 A FI 893587A FI 893587 A FI893587 A FI 893587A
Authority
FI
Finland
Prior art keywords
recombinant human
reduced form
producing non
glycosylated recombinant
glycosylated
Prior art date
Application number
FI893587A
Other languages
English (en)
Finnish (fi)
Other versions
FI96209B (sv
FI96209C (sv
FI893587A0 (sv
Inventor
Danielle Lando
Philippe Riberon
Pierre Yves Abecassis
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of FI893587A0 publication Critical patent/FI893587A0/sv
Publication of FI893587A publication Critical patent/FI893587A/sv
Publication of FI96209B publication Critical patent/FI96209B/sv
Application granted granted Critical
Publication of FI96209C publication Critical patent/FI96209C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
FI893587A 1988-07-28 1989-07-27 Förfarande för framställning av icke-glykosylerad rekombinant-human-IL2 i dess reducerade form FI96209C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8810184A FR2635527B1 (fr) 1988-07-28 1988-07-28 Il2 humaine recombinante non glycosylee sous forme reduite, son procede d'obtention et son application comme medicament
FR8810184 1988-07-28

Publications (4)

Publication Number Publication Date
FI893587A0 FI893587A0 (sv) 1989-07-27
FI893587A true FI893587A (sv) 1990-01-29
FI96209B FI96209B (sv) 1996-02-15
FI96209C FI96209C (sv) 1996-05-27

Family

ID=9368873

Family Applications (1)

Application Number Title Priority Date Filing Date
FI893587A FI96209C (sv) 1988-07-28 1989-07-27 Förfarande för framställning av icke-glykosylerad rekombinant-human-IL2 i dess reducerade form

Country Status (21)

Country Link
US (2) US5874076A (sv)
EP (1) EP0353150B1 (sv)
JP (1) JP3016793B2 (sv)
KR (1) KR0131070B1 (sv)
CN (1) CN1036532C (sv)
AT (1) ATE110783T1 (sv)
AU (1) AU624625B2 (sv)
DE (1) DE68917826T2 (sv)
DK (1) DK370489A (sv)
ES (1) ES2058573T3 (sv)
FI (1) FI96209C (sv)
FR (1) FR2635527B1 (sv)
HU (1) HU207099B (sv)
IE (1) IE64232B1 (sv)
IL (1) IL90975A (sv)
MX (1) MX16912A (sv)
NZ (1) NZ230111A (sv)
PT (1) PT91295B (sv)
RU (1) RU2105011C1 (sv)
UA (1) UA26846C2 (sv)
ZA (1) ZA895419B (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660863B1 (fr) * 1990-04-17 1994-01-21 Roussel Uclaf Utilisation d'un polypeptide ayant l'activite de l'interleukine 2 humaine pour preparer une composition pharmaceutique destinee au traitement de cancers primitifs de la plevre.
FR2668368B1 (fr) * 1990-10-30 1995-03-10 Roussel Uclaf Utilisation d'un polypeptide ayant l'activite de l'interleukine 2 humaine pour preparer une composition pharmaceutique destinee au traitement des tumeurs malignes epitheliales.
DE69031596T2 (de) * 1990-11-23 1998-02-26 Roussel Uclaf Verfahren zur herstellung eines proteins gehörend zu der klasse der cytokine, das mindestens eine intramolekulare disulfidbrücke enthält, durch oxidation bei einem ph-wert kleiner als 5.0 des entsprechenden rekombinanten reduzierten proteins
FR2671728B1 (fr) * 1991-01-17 1995-01-20 Roussel Uclaf Utilisation d'un polypeptide ayant l'activite de l'interleukine 2 humaine pour la preparation de compositions pharmaceutiques destinees au traitement des pneumathorax.
FR2684878B1 (fr) * 1991-12-12 1994-02-11 Roussel Uclaf Composition pharmaceutique stabilisee d'il2 humaine recombinante non glycosylee sous forme reduite et son procede de preparation.
US6470207B1 (en) * 1999-03-23 2002-10-22 Surgical Navigation Technologies, Inc. Navigational guidance via computer-assisted fluoroscopic imaging
US20050203578A1 (en) * 2001-08-15 2005-09-15 Weiner Michael L. Process and apparatus for treating biological organisms
RU2372356C2 (ru) * 2003-08-07 2009-11-10 Займоджинетикс, Инк. Полипептид с антивирусной активностью, его получение и применение
JP7303391B2 (ja) 2020-01-14 2023-07-04 シンセカイン インコーポレイテッド バイアス型ｉｌ２ムテイン、方法、および組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341562C (en) * 1982-03-31 2007-11-27 Tadatsugu Taniguchi Gene coded for interleukin-2 polypeptide, recombinant dna carrying the said gene, a living cell line possessing the recombinant dna, and method for producing interleukin-2 using the said cell
US5643566A (en) * 1982-09-23 1997-07-01 Cetus Corporation Formulation processes for lipophilic proteins
US4518584A (en) * 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
JPS60115528A (ja) * 1983-11-28 1985-06-22 Takeda Chem Ind Ltd ヒトインタ―ロイキン―２蛋白質を含有する抗腫瘍用または免疫機能低下疾患治療用組成物
US4604377A (en) * 1984-03-28 1986-08-05 Cetus Corporation Pharmaceutical compositions of microbially produced interleukin-2
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
EP0158487B1 (en) * 1984-04-09 1991-08-28 Takeda Chemical Industries, Ltd. Stable composition of interleukin-2
US4654830A (en) * 1984-11-27 1987-03-31 Monolithic Memories, Inc. Method and structure for disabling and replacing defective memory in a PROM
US4690915A (en) * 1985-08-08 1987-09-01 The United States Of America As Represented By The Department Of Health And Human Services Adoptive immunotherapy as a treatment modality in humans
JPH0829113B2 (ja) * 1986-11-11 1996-03-27 武田薬品工業株式会社 ヒトインタ−ロイキン−２の製造法

Also Published As

Publication number Publication date
MX16912A (es) 1993-10-01
HUT51647A (en) 1990-05-28
ZA895419B (en) 1990-09-26
HU207099B (en) 1993-03-01
US5814314A (en) 1998-09-29
DK370489D0 (da) 1989-07-27
ATE110783T1 (de) 1994-09-15
DE68917826D1 (de) 1994-10-06
IL90975A (en) 1994-11-28
JPH02209896A (ja) 1990-08-21
IE64232B1 (en) 1995-07-26
FR2635527B1 (fr) 1992-06-12
FI96209B (sv) 1996-02-15
PT91295A (pt) 1990-02-08
KR900001854A (ko) 1990-02-27
IE892443L (en) 1990-01-28
EP0353150B1 (fr) 1994-08-31
KR0131070B1 (ko) 1998-04-11
DE68917826T2 (de) 1995-01-12
FI96209C (sv) 1996-05-27
AU624625B2 (en) 1992-06-18
FI893587A0 (sv) 1989-07-27
ES2058573T3 (es) 1994-11-01
EP0353150A1 (fr) 1990-01-31
CN1042377A (zh) 1990-05-23
IL90975A0 (en) 1990-02-09
RU2105011C1 (ru) 1998-02-20
FR2635527A1 (fr) 1990-02-23
PT91295B (pt) 1995-03-01
NZ230111A (en) 1992-04-28
UA26846C2 (uk) 1999-12-29
DK370489A (da) 1990-01-29
CN1036532C (zh) 1997-11-26
JP3016793B2 (ja) 2000-03-06
AU3902489A (en) 1990-02-01
US5874076A (en) 1999-02-23

Similar Documents

Publication Publication Date Title
DE69033040T2 (de) Verfahren zur Herstellung von biologisch aktivem Protein (z.B. TGF)
HU9200548D0 (en) Improved activity process of recombined proteins
FI893587A (sv) Förfarande för framställning av icke-glykosylerad rekombinant-human-IL2 i dess reducerade form
DE69126049D1 (de) Vektoren und Zusammensetzungen zur Expression von Glykosilationsmutanten des menschlichen Proteins-C
DE68917061D1 (de) O-glycosylierter IGF-1.
DE69106407D1 (de) Verfahren zur Herstellung von rekombinantem menschlichem gamma-Interferon ohne Cystein und ohne Methionin am N-Terminal.

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: HOECHST MARION ROUSSEL

MM Patent lapsed

Owner name: HOECHST MARION ROUSSEL